Following the initial discovery of biallelic germline MCM8/MCM9 variants in families with CRC, polyposis, and hypogonadism,2,3,4 we present a comprehensive clinical and molecular characterization of biallelic MCM8/MCM9 variant carriers from multiple sources. This evidence concerns the gene MCM8 and colorectal carcinoma.